Globe Life Inc. $GL Shares Sold by Bayview Asset Management LLC

Bayview Asset Management LLC reduced its position in shares of Globe Life Inc. (NYSE:GL) by 40.0% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 3,000 shares of the company’s stock after selling 2,000 shares during the period. Globe Life comprises approximately 0.1% of Bayview Asset Management LLC’s portfolio, making the stock its 21st largest position. Bayview Asset Management LLC’s holdings in Globe Life were worth $373,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. AdvisorNet Financial Inc raised its stake in Globe Life by 60.0% in the second quarter. AdvisorNet Financial Inc now owns 224 shares of the company’s stock valued at $28,000 after buying an additional 84 shares in the last quarter. Intech Investment Management LLC increased its holdings in shares of Globe Life by 0.8% in the 2nd quarter. Intech Investment Management LLC now owns 11,572 shares of the company’s stock valued at $1,438,000 after acquiring an additional 95 shares during the last quarter. Creative Planning increased its holdings in shares of Globe Life by 0.3% in the 2nd quarter. Creative Planning now owns 36,855 shares of the company’s stock valued at $4,581,000 after acquiring an additional 101 shares during the last quarter. Kovitz Investment Group Partners LLC raised its position in shares of Globe Life by 2.9% during the 1st quarter. Kovitz Investment Group Partners LLC now owns 3,609 shares of the company’s stock worth $475,000 after acquiring an additional 102 shares in the last quarter. Finally, Geneos Wealth Management Inc. lifted its stake in Globe Life by 3.1% during the first quarter. Geneos Wealth Management Inc. now owns 3,717 shares of the company’s stock worth $490,000 after purchasing an additional 113 shares during the last quarter. Institutional investors and hedge funds own 81.61% of the company’s stock.

Globe Life Trading Down 0.1%

NYSE GL opened at $134.73 on Monday. The stock has a market capitalization of $10.73 billion, a P/E ratio of 9.76 and a beta of 0.55. Globe Life Inc. has a 52-week low of $100.27 and a 52-week high of $147.83. The firm has a 50-day moving average price of $135.67 and a 200 day moving average price of $131.71. The company has a quick ratio of 0.06, a current ratio of 0.06 and a debt-to-equity ratio of 0.43.

Globe Life (NYSE:GL) last issued its earnings results on Wednesday, October 22nd. The company reported $4.81 EPS for the quarter, topping the consensus estimate of $4.54 by $0.27. Globe Life had a net margin of 19.36% and a return on equity of 22.12%. The company had revenue of $1.51 billion for the quarter, compared to analyst estimates of $1.52 billion. During the same period in the previous year, the firm earned $3.44 EPS. Globe Life has set its FY 2026 guidance at 14.600-15.300 EPS. FY 2025 guidance at 14.400-14.600 EPS. Equities research analysts expect that Globe Life Inc. will post 13.87 EPS for the current year.

Globe Life Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 30th. Investors of record on Monday, January 5th will be issued a dividend of $0.27 per share. The ex-dividend date of this dividend is Monday, January 5th. This represents a $1.08 annualized dividend and a yield of 0.8%. Globe Life’s payout ratio is currently 7.83%.

Analysts Set New Price Targets

Several equities analysts have commented on the stock. Piper Sandler reiterated an “overweight” rating and issued a $167.00 price target on shares of Globe Life in a research note on Friday, November 21st. Morgan Stanley lowered their target price on shares of Globe Life from $179.00 to $177.00 and set an “overweight” rating for the company in a report on Monday, November 17th. Wells Fargo & Company cut their price target on shares of Globe Life from $172.00 to $170.00 and set an “overweight” rating on the stock in a research note on Friday, October 24th. Keefe, Bruyette & Woods boosted their price target on shares of Globe Life from $160.00 to $162.00 and gave the company an “outperform” rating in a research report on Tuesday, October 28th. Finally, Weiss Ratings downgraded shares of Globe Life from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Monday, November 24th. Seven equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $155.56.

Globe Life Profile

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.